SPECT	Single-photon emission computed tomography
TRT	Targeted radionuclide therapy
LET	Linear energy transfer
DNA	Deoxyribonucleic acid
BFC	Bifunctional chelator
PET	Positron emission tomography
CT	Computed tomography
hCTR1	Human copper transporter receptor 1
ATOX1	Antioxidant 1 copper chaperone
BMS2P2	2-nitroimidazole derivative
DOTA	S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-tetraacetic acid
PCTA	3,6,9,15-tetraazabicyclo [9.3.1] pentadeca-1(15),11,13-triene-4-S-(4 isothiocyanatobenzyl)-3,6,9-triacetic acid
PSMA	Prostate-specific membrane antigen
NOTA	1,4,7-triazacyclononane-N,N′,N″-triacetic acid
NET	Neuroendocrine tumors
EDTMP	Ethylenediamine tetra(methylene phosphonic acid)
GIST	Gastrointestinal stromal tumor
TKI	Tyrosine kinase inhibitor drugs
PDGFR	Platelet-derived growth factor receptor
NT1	Neurotensin 1
SST2A	Somatostatin receptor
VPAC2	Vasoactive intestinal peptide receptor type 2
GRP	Gastrin-releasing peptide receptor
CCK2	Cholecystokinin receptors
AMBA	4-(Aminomethyl)benzoic acid
TREM-2	Marker triggering receptor expressed on myeloid cells 2
COG1410	Apolipoprotein E (apoE) mimetic small peptide
TAM	Tumor-associated macrophages
BON-1	Pancreatic neuroendocrine tumor cells
QGP1	Human pancreatic endocrine cell line
NCI-H727	Bronchial carcinoid cell
GOT1	Human small intestine NET cell line
GUL	Glu-urea-lys
CXCR4	C-X-C chemokine receptor type 4
IGF2R	Insulin-like growth factor 2 receptor
NSCLC	Non-small cell lung cancer
MIBI	Hexakis-2-methoxyisobutylisonitrile
[99mTc]Tat-BN	[99mTc]N2S2-Tat(49–57)-Lys3-bombesin